Terkko Navigator / Knip, M(ikael) (PRC)*

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

Author Correction: Maternal breast milk microbiota and immune markers in relation to subsequent development of celiac disease in offspring

Maternal breast milk microbiota and immune markers in relation to subsequent development of celiac disease in offspring

Viral infection-related gene upregulation in monocytes in children with signs ofβ-cell autoimmunity

Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes

Sources of dietary gluten in the first two years of life and associations with celiac disease autoimmunity and celiac disease in Swedish genetically predisposed children: TEDDY study

Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study

Permutation-based significance analysis reduces the type 1 error rate in bisulfite sequencing data analysis of human umbilical cord blood samples

Heterogeneity of Type 1 Diabetes at Diagnosis Supports Existence of Age-Related Endotypes

Early DNA methylation changes in children developing beta cell autoimmunity at a young age

Seasonality in the manifestation of type 1 diabetes varies according to age at diagnosis in Finnish children

Type 1 Diabetes in Children With Genetic Risk May Be Predicted Very Early With a Blood miRNA

Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study

Is staff consistency important to parents' satisfaction in a longitudinal study of children at risk for type 1 diabetes: the TEDDY study

Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA

Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes

Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes

Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study

Dynamic changes in immune gene co-expression networks predict development of type 1 diabetes

Determining the timing of pubertal onset via a multicohort analysis of growth

Maternal energy-adjusted fatty acid intake during pregnancy and the development of cows' milk allergy in the offspring

Autoantibodies to N-Terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes

Exposure to per- and polyfluoroalkyl substances associates with an altered lipid composition of breast milk

Frailty modeling under a selective sampling protocol: an application to type 1 diabetes related autoantibodies

Consumption of differently processed milk products and the risk of asthma in children

Dietary compliance in a randomized double-blind infant feeding trial during infancy aiming at prevention of type 1 diabetes

Higher circulating EGF levels associate with a decreased risk of IgE sensitization in young children

Increasing plasma glucose before the development of type 1 diabetes-the TRIGR study

Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts

Tri-SNP polymorphism in the intron of HLA-DRA1 affects type 1 diabetes susceptibility in the Finnish population

Effect of Early Feeding on Intestinal Permeability and Inflammation Markers in Infants with Genetic Susceptibility to Type 1 Diabetes: A Randomized Clinical Trial

Association of different enteroviruses with atopy and allergic diseases in early childhood

Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S

New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic

Land Cover of Early-Life Environment Modulates the Risk of Type 1 Diabetes

Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1

Maternal Vitamin C and Iron Intake during Pregnancy and the Risk of Islet Autoimmunity and Type 1 Diabetes in Children: A Birth Cohort Study

Type 1 diabetes in Finland: past, present, and future

Generation of self-reactive, shared T-cell receptorα chains in the human thymus

Immunomodulatory Effects of Rhinovirus and Enterovirus Infections During the First Year of Life

An Age-Related Exponential Decline in the Risk of Multiple Islet Autoantibody Seroconversion During Childhood

Letter to the Editor from Pöllänen et al: "Birth Cohorts in Type 1 Diabetes: Preparing for the Payoff"

Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study

Allergy-Related Symptoms Are Poorly Predicted by IgE and Skin Prick Testing in Early Life

Serum fatty acids and risk of developing islet autoimmunity: A nested case-control study within the TRIGR birth cohort

Perturbation of nuclear-cytosolic shuttling of Rx1 compromises extreme resistance and translational arrest of potato virus X transcripts

Diabetic Ketoacidosis at the Time of Diagnosis of Type 1 Diabetes in Children: Insights From TRIGR

Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk

Effect of extensively hydrolyzed casein vs. conventional formula on the risk of asthma and allergies: The TRIGR randomized clinical trial